Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"F0P408N6V4"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Usmani%2C+Saad+Z%22&type=Person&filter%5B%5D=topic_facet%3A%22F0P408N6V4%22
/vufind/Search/Results?lookfor=%22Usmani%2C+Saad+Z%22&type=Person&filter%5B%5D=topic_facet%3A%22F0P408N6V4%22
Search /vufind/Search2/Results?lookfor=%22Usmani%2C+Saad+Z%22&type=Person&filter%5B%5D=topic_facet%3A%22F0P408N6V4%22
PubPharm (38)
1
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
enthalten in:
Blood cancer journal
| 2024
von
Callander, N.
|
Silbermann, R.
|
Kaufman, J.
| +33
Wird geladen...
2
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data
enthalten in:
Advances in therapy
| 2024
von
Durie, B.
|
Kumar, S.
|
Ammann, E.
| +5
Wird geladen...
3
Daratumumab for patients with myeloma with early or late relapse after initial therapy : subgroup analysis of CASTOR and POLLUX
enthalten in:
Blood advances
| 2024
von
Spencer, A.
|
Moreau, P.
|
Mateos, M.
| +17
Wird geladen...
4
Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma : TAURUS Chart Review Study
enthalten in:
Clinical lymphoma, myeloma & leukemia
| 2024
von
Gordan, L.
|
Tan, C.
|
Vescio, R.
| +12
Wird geladen...
5
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
enthalten in:
Nature cancer
| 2023
von
Maura, F.
|
Boyle, E.
|
Coffey, D.
| +34
Wird geladen...
6
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN) : final analysis of an open-label, randomised, phase 2 trial
enthalten in:
The Lancet. Haematology
| 2023
von
Voorhees, P.
|
Sborov, D.
|
Laubach, J.
| +25
CommentIn: Lancet Haematol. 2023 Oct;10(10):e788-e789. - PMID 37793762
Wird geladen...
7
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
enthalten in:
Blood cancer journal
| 2023
von
Tan, C.
|
Derkach, A.
|
Nemirovsky, D.
| +18
UpdateOf: Res Sq. 2023 Feb 24;:. - PMID 36865246
Wird geladen...
8
A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse
enthalten in:
Clinical lymphoma, myeloma & leukemia
| 2023
von
Bhutani, M.
|
Foureau, D.
|
Robinson, M.
| +14
Wird geladen...
9
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma : a CIBMTR analysis
enthalten in:
Blood advances
| 2023
von
Ragon, B.
|
Shah, M.
|
D'Souza, A.
| +39
CommentIn: Blood Adv. 2023 Jun 27;7(12):2731-2732. - PMID 37318936
Wird geladen...
10
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX) : A Randomized, Open-Label, Phase III Trial
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Dimopoulos, M.
|
Oriol, A.
|
Nahi, H.
| +19
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: F0P408N6V4
Medienart
38
Aufsätze
38
E-Artikel
38
E-Ressourcen
Zeitschriftentitel
4
Clinical lymphoma, myeloma & leukemia
3
Blood cancer journal
3
Journal of clinical oncology : official journal...
3
The Lancet. Haematology
2
Advances in therapy
2
Blood
2
Blood advances
2
Haematologica
2
Leukemia
2
The New England journal of medicine
1
American journal of hematology
1
BMC cancer
1
Bone marrow transplantation
1
British journal of haematology
1
Cancer
1
Cancer cell
1
Current medical research and opinion
1
Future oncology (London, England)
1
JAMA oncology
1
Nature cancer
Alle anzeigen ...
weniger ...
Thema
F0P408N6V4
38
Lenalidomide
35
Journal Article
29
7S5I7G3JQL
29
Dexamethasone
22
Research Support, Non-U.S. Gov't
21
4Z63YK6E0E
21
daratumumab
18
Antibodies, Monoclonal
16
69G8BD63PP
16
Bortezomib
14
Randomized Controlled Trial
13
Multicenter Study
9
Clinical Trial, Phase III
8
4Z8R6ORS6L
8
Thalidomide
6
Research Support, N.I.H., Extramural
5
72X6E3J5AR
5
carfilzomib
4
Daratumumab
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
28
2020-
10
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
38
Englisch
Haven't found what you're looking for?
Wird geladen...